Gyre Therapeutics, Inc.

GYRE ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jun 10, 2026 FORM 4
S-8 Jun 10, 2026 S-8
4 Jun 8, 2026 FORM 4
8-K Jun 2, 2026 8-K
4 May 27, 2026 FORM 4
4 May 22, 2026 FORM 4
4 May 20, 2026
4 May 20, 2026 FORM 4
4 May 18, 2026 FORM 4
8-K May 14, 2026 8-K
8-K May 12, 2026 8-K
144 May 11, 2026
10-Q May 8, 2026 10-Q
4 May 7, 2026 FORM 4
3 May 7, 2026 FORM 3
3 May 7, 2026 FORM 3
3 May 7, 2026 FORM 3
3 May 7, 2026 FORM 3
SCHEDULE 13D/A May 7, 2026
8-K May 7, 2026 8-K
SCHEDULE 13D/A May 6, 2026
SCHEDULE 13D/A May 6, 2026
4 May 6, 2026 FORM 4
4 May 6, 2026 FORM 4
DEFA14A May 4, 2026 DEFA14A
← Newer Page 2 of 65 · 1601 filings Older →